Integrated Clinicopathological Model versus TNM for Predicting Survival in Resected Hepatocellular Carcinoma: A Retrospective Cohort Study
Authors:
Preprint
- 30 April 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective To explore prognostic factors of postoperative hepatocellular carcinoma (HCC) and compare the prognostic performance of the tumor–node–metastasis (TNM) system with an integrated clinicopathological model. Methods We conducted a cohort study evaluating 249 patients with HCC who underwent radical liver resection between January 2015 and December 2024. Overall survival (OS) was the primary endpoint. Independent prognostic factors were determined using the Cox proportional hazards model. Model performance was assessed using the correlation index (C-index) with bootstrap internal validation. Time-dependent receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots were used to assess discrimination, clinical utility, and agreement between predicted and observed outcomes. Results In multivariable analysis, TNM stage, microvascular invasion (MVI), resection margin status, and albumin–bilirubin (ALBI) grade were independent predictors of OS. For recurrence-free survival (RFS), independent predictors included hepatitis status, ALBI grade, TNM stage, and MVI. The integrated model demonstrated improved discrimination compared with TNM alone, with a higher optimism-corrected C-index (0.676 vs. 0.647). Time-dependent ROC analysis showed significantly higher AUC values for the integrated model at 1 year (0.725 vs. 0.669, p=0.046), 3 years (0.703 vs. 0.657, p=0.024), and 5 years (0.684 vs. 0.649, p=0.031). DCA indicated greater net benefit across clinically relevant thresholds, and calibration plots showed good agreement between predicted and observed survival probabilities. Conclusion An integrated clinicopathological model incorporating TNM stage, MVI, ALBI grade, and resection margin status improves prognostic performance compared with TNM alone in patients undergoing curative resection for HCC. This model may support more accurate postoperative risk stratification.Keywords
All Related Versions
- Version 1, 2026-04-30, Research Square
- Published version: BMC Gastroenterology, 26.
This publication has 34 references indexed in Scilit:
- Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection marginScientific Reports, 2024
- Significance of anatomical resection and wide surgical margin for HCC patients with MVI undergoing laparoscopic hepatectomy: A multicenter studyEuropean Journal of Surgical Oncology, 2024
- Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resectionLangenbeck's Archives of Surgery, 2023
- The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular InvasionThe Oncologist, 2023
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studiesHepatology Communications, 2022
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional studyHPB, 2019
- A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resectionClinica Chimica Acta, 2018
- Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinomaAnnals of Gastroenterological Surgery, 2018